Publications (2)11.95 Total impact
-
Article: Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B
Cancer Research 01/2009; 69(1):178-184. · 7.86 Impact Factor -
Article: Shen T, Kuang YH, Ashby CR, Lei Y, Chen A, Zhou Y, Chen X, Tiwari AK, Hopper-Borge E, Ouyang J, Chen ZS. Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10). PLoS One. 2009;4(10):e7520
PLoS ONE 01/2009; 4(10):e7520. · 4.09 Impact Factor